Parx Plastics appoints new CFO to take company through next phase of growth.
Clean tech/biochemistry plastic developer expands its executive team with the addition of seasoned professional in investment management Felix Guépin.
Rotterdam – September 1, 2017 – Parx Plastics, a topmost player in the field of antimicrobial plastics invests in new executive talent with the hiring of Felix Guépin as Chief Financial Officer (CFO). Mr Guépin is a seasoned professional with extensive experience in investment management, funding, deal making and (legal) structuring. During his career, he has been involved in M&A deals, raised capital and managed multiple shareholder exits.
“Felix brings on board expertise that that will be of great value on our road ahead.” Michael van der Jagt, CEO, Parx Plastics said. “His past experience ‘on the other side of the table’ will allow us to take a proactive and well-targeted approach dealing with new financing for further growth and maintaining good investor relations.”
About Parx Plastics
Parx Plastics with its headquarters in Rotterdam (The Netherlands) brings to the market a promising patented biocompatible technique to incorporate a 99% effective antimicrobial property in any plastic. The technology is suitable for a wide array of applications but it is specifically suitable for food contact applications and medical applications. Learn more at: www.parxplastics.com